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The role of apoptosis in the formation and regression
of neovascularization is largely hypothesized, al-
though the detailed mechanism remains unclear. In-
flammatory cells and endothelial cells both partici-
pate and interact during neovascularization. During
the early stage, these cells may migrate into an angio-
genic site and form a pro-angiogenic microenviron-
ment. Some angiogenic vessels appear to regress,
whereas some vessels mature and remain. The con-
trol mechanisms of these processes, however, remain
unknown. Previously, we reported that the preven-
tion of mitochondrial apoptosis contributed to cellu-
lar survival via the prevention of the release of pro-
apoptotic factors, such as apoptosis-inducing factor
(AIF) and cytochrome c. In this study, we investigated
the regulatory role of cellular apoptosis in angiogen-
esis using two models of ocular neovascularization:
laser injury choroidal neovascularization and VEGF-
induced corneal neovascularization in AIF-deficient
mice. Averting apoptosis in AIF-deficient mice de-
creased apoptosis of leukocytes and endothelial cells
compared to wild-type mice and resulted in the per-
sistence of these cells at angiogenic sites in vitro and
in vivo. Consequently, AIF deficiency expanded neo-
vascularization and diminished vessel regression in
these two models. We also observed that peritoneal
macrophages from AIF-deficient mice showed anti-
apoptotic survival compared to wild-type mice underconditions of starvation. Our data suggest that AIF-
related apoptosis plays an important role in neovas-
cularization and that mitochondria-regulated apopto-
sis could offer a new target for the treatment of
pathological angiogenesis. (Am J Pathol 2012, 181:53–61;
http://dx.doi.org/10.1016/j.ajpath.2012.03.022)
The mitochondrial apoptosis pathways are important
mechanisms of cell death.1 Mitochondria contain pro-
apoptotic factors such as cytochrome c and apoptosis-
inducing factor (AIF) in their intermembrane space.
Furthermore, mitochondrial outer membrane permeabi-
lization is a critical event during apoptosis, representing
the “point of no return” of the lethal process. Cytochrome
c is released from mitochondria on mitochondrial outer
membrane permeabilization and binds to cytosolic apop-
totic protease activating factor-1 to induce its dimeriza-
tion and a conformational change.2 Apoptotic protease
activating factor-1 then oligomerizes into apoptosomes
that recruit and activate caspase-9 followed by serial
activation of apoptosis-execution molecules.3,4 Mito-
chondrial outer membrane permeabilization, however,
may cause cell death even if caspases are inhibited5 and
a broad caspase inhibitor (z-VAD-fmk) fails to block
apoptosis in retinal neurons.6 AIF is a caspase-indepen-
dent apoptogenic factor and is normally confined to the
mitochondrial intermembrane space.7 Most cell death in
vertebrates proceeds via the mitochondrial pathway of
apoptosis, especially in mammalian cells.8,9 During
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nucleus where it triggers peripheral chromatin conden-
sation and interacts with cyclophilin A to generate a
DNase complex, which is responsible for the so-called
“large-scale” DNA degradation to fragments of approxi-
mately 50 kbp.10 AIF is strongly conserved among mam-
malian species (95% amino acid identity between
mouse and human) and bears a highly significant homol-
ogy with flavoprotein oxidoreductases from all eukaryotic
and prokaryotic kingdoms in its C-terminal portion.7 Be-
cause AIF, a central player in mitochondrial apoptotic
pathways is essential in the developmental process, AIF
knockout mice die in utero.11 Based on these findings, it
is reasonable to speculate that AIF may be a phyloge-
netically old major mediator participating in various as-
pects of the apoptotic process. Because we originally
reported AIF translocation in mammalian cells in vivo in
retinal cell death,6,9,12–16 the translocation of AIF has
been reported in neurodegeneration17,18 and retinal de-
generation.19 The contribution of apoptosis, especially
phylogenetically old major factors (ie, AIF), however, has
remained elusive in the field of neovascularization.
Choroidal neovascularization (CNV) is a pathological
process involving the formation of new blood vessels
from choroidal vasculature through Bruch’s membrane
breaks. CNV is associated with a variety of ocular dis-
eases, including age-related macular degeneration
(AMD), myopia, histoplasmosis, angioid streaks, tumors,
and traumatic and idiopathic conditions, all of which often
cause severe visual loss via retinal degeneration. CNV
could be induced by focally increased inflammatory and
proangiogenic factors, and/or by a decrease of anti-an-
giogenic factors. Various clinical, as well as experimen-
tal, studies have shown that vascular endothelial growth
factor (VEGF)-A could be the most important factor for
CNV.20 Recent observations in age-related macular de-
generation patients with VEGF-A inhibition strongly sup-
port the importance in CNV. In CNV, macrophages may
be major sources of VEGF-A, which would enhance vas-
cular leakage, as well as angiogenesis via vascular en-
dothelial growth factor receptor (VEGFR)-2.21 Macro-
phage also expresses VEGFR-1 and VEGF-A that may
induce macrophage infiltration. Thus, VEGF is an inflam-
matory cytokine targeting both leukocytes and endothe-
lial cells. Various studies have shown attachment of mural
cells is important for the vascular stability that is depen-
dent on angiopoietin/Tie system and VEGF.22 Tie2 is
known to play a direct role in pericyte recruitment and
Tie2-knockout blood vessels that lack mural cells.23 The
loss of periendothelial cells in the mutants is secondary to
endothelial cell apoptosis.24
The efficient clearance of excessive inflammatory cells
and neovascular endothelial cells from the pathological
sites may be essential for restoration of tissue homeosta-
sis.13 The regulation of apoptosis in angiogenesis-related
cells, including leukocytes and endothelial cells, may
occur in various disorders. The detailed mechanism,
however, remains unclear.25 In this study, we focused on
the roles of a major proapoptotic molecule, AIF in the
formation and regression of neovascularization.Materials and Methods
Experimental Animals
All animal procedures were performed in accordance
with the statement of the Association for Research in
Vision and Ophthalmology and the protocol approved by
the Animal Care Committee of Massachusetts Eye and
Ear Infirmary. The AIF mutant mice (B6CBACa Aw-J/A-
Aifm1Hq/J, stock number 000501; Jackson Laboratory,
Bar Harbor, ME) and wild type (WT) from the colony were
purchased from the Jackson Laboratory and bred in our
laboratory. Adult male mice (8 weeks of age) were used
for the following experiments.
Laser Injury-Induced Choroidal Neovascularization
Mice were anesthetized with ketamine (100 mg/kg) and
xylazine (10 mg/kg). Pupils were dilated with 5.0% phenyl-
ephrine and 0.8% tropicamide. CNV was induced with a
532 nm laser (Oculight GLx, Iridex, Mountain View, CA) as
previously described.20,26–31 Four laser spots (150 mW,
100 msec, 50 m settings) were placed in each eye using
a slit-lamp delivery system and a cover glass as a contact
lens (n 16 for each time point and strain). Production of a
bubble at the time of laser confirmed the rupture of the
Bruch’s membrane. The vessels were stained with fluores-
cein isothiocyanate-dextran. The eyes were enucleated at
2, 4, and 12 weeks after laser injury and fixed in 4% para-
formaldehyde for 3 hours. The anterior segment and retina
were removed from the eyecup. Approximately four to six
relaxing radial incisions were made, and the remaining ret-
inal pigment epithelial-choroidal-scleral complex was flat
mounted and coverslipped. Pictures of the choroidal flat
mounts were taken, and Openlab software version 5 (Im-
provision, Boston, MA) was used to measure the hyperfluo-
rescent areas corresponding to the CNV lesions. The aver-
age size of the CNV lesions was then determined and used
for the evaluation.
Bone Marrow Transplantation
To characterize the angiogenic roles of infiltrating mac-
rophages, we produced chimera green fluorescent pro-
tein (GFP) mice, by a previously described method.13,32
Briefly, we used the transgenic mouse as a cell source for
enhanced GFP (EGFP)-positive bone marrow cells. The
host mice took 1,4-butanediol dimethanesulfonate,
Busulfan 4  25 mg/kg on 4 consecutive days followed
by bone marrow transplantation (BMT) to deplete stem
cells in the host and consequently allow for high levels of
long-term, donor-type engraftment. A successful bone
marrow transplantation was confirmed by the identifica-
tion of GFP-positive cells in the blood at 2 and 4 weeks
after BMT. The WT and AIF-deficient mice took BMT from
EGFP transgenic mice and laser injury 4 weeks after BMT
(n  10, each group). The eyes were harvested and
examined 2 weeks after laser injury, as previously de-
scribed. To visualize EGFP-positive macrophage in the
CNV, the vessels were stained with rhodamine-conju-
gated concanavalin A.
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Mice were anesthetized with ketamine (100 mg/kg) and
xylazine (10 mg/kg). Poly 2-hydroxyethyl methacrylate pel-
lets (0.3 L, P3932; Sigma-Aldrich, St. Louis, MO) contain-
ing 200 ng VEGF-A (293-VE; R&D Systems, Minneapolis,
MN) were prepared and implanted into the corneas.
VEGF-A pellets were positioned at approximately 1 mm
distant to the corneal limbus. After implantation, bacitracin
ophthalmic ointment (E. Fougera & Co., Melville, NY) was
applied to each eye to prevent infection. At 6 days (n  6,
each group), 10 days (n  8), 14 days (n  10), 28 days
(n  8), 56 days (n  10), 84 days (n  5), and 140 days
(n 3) after implantation, digital images of the corneal vessels
were obtained and recorded using OpenLab software version
(Improvision Inc., Lexington, MA) with standardized illumina-
tion and contrast. The quantitative analysis of neovasculariza-
tion in the mouse corneas was performed using Scion Image
software (version 4.0.2; Scion Corp., Frederick, MD).
TUNEL Assay
TUNEL and quantification of TUNEL cells were performed
as previously described,6 using the ApopTag Fluorescein in
Situ Apoptosis Detection Kit (Chemicon/Millipore, Bedford,
MA). The center of the choroidal and corneal neovascular-
ization was photographed, and the number of TUNEL cells
in the microscopic field was counted in a masked fashion.
The results are presented as the mean  SD.
Immunohistochemistry
The eyes were harvested and snap-frozen in optimal cutting
temperature compound (Sakura Finetechnical). Sections
(10 m) were prepared, air dried, and fixed in ice-cold
acetone for 10 minutes. The sections were blocked with 3%
nonfat dried milk bovine working solution (M7409; Sigma-
Aldrich) and stained with a macrophage marker, anti-
mouse CD11b (1:50, BD Pharmingen, San Diego, CA) or an
endothelial marker, anti-mouse CD31 mAb (1:50; BD Phar-
mingen), a myeloid lineage marker, CD45 (1:100, BD Phar-
mingen), VEGF, TNF- (1:100, Santa Cruz Biotechnology,
Santa Cruz, CA), basic fibroblast growth factor, IL-1 (Ab-
cam, Cambridge, MA), and rabbit anti-AIF (1:50, R&D Sys-
tems).33 After an overnight incubation, sections were
washed and stained for 40 minutes with Alexa Fluor488
goat anti-rat IgG (20 g/mL, A11006; Invitrogen). The spec-
imens were observed with a fluorescent microscope and
confocal microscope (Nikon, Tokyo, Japan).
Transmission Electron Microscopy
The eyes were enucleated and the posterior segments
were fixed in 2.5% glutaraldehyde and 2% paraformal-
dehyde in 0.1 mol/L cacodylate buffer with 0.08 mol/L
CaCl2 at 4°C. The specimens were postfixed for 1.5 hours
in 2% aqueous OsO4, dehydrated in ethanol and water,
and embedded in Epon (Electron Microscopy Sciences,
Hatfield, PA). Ultrathin sections were cut from blocks and
stained with saturated, aqueous uranyl acetate and Sa-
to’s lead stain. The specimens were observed with a
Hitachi H-7650 electron microscope.Fluorescein Angiography in CNV Model
Fluorescein angiography was performed by an operator
masked to the genetic identity of the animal, with a com-
mercial camera and imaging system (TRC 50 VT camera
and IMAGEnet 1.53 system; Topcon, Paramus, NJ), at 2
weeks after laser photocoagulation (WT mice; n  12,
AIF-deficient mice; n  12). The photographs were cap-
tured with a 20-dimensional lens in contact with the fun-
dus camera lens, after intraperitoneal injection of 0.1 mL
of 1% fluorescein sodium (Akorn, Decatur, IL). Two
masked retina specialists evaluated the fluorescein angio-
grams at a single sitting. Lesions were graded on an ordinal
scale based on the spatial and temporal evolution of fluo-
rescein leakage as follows: grade 0 (nonleaky): no leakage,
faint hyperfluorescence, or mottled fluorescence without
leakage; grade1 (questionable leakage): hyperfluorescent
lesion without progressive increase in size or intensity;
grade 2A (leaky): hyperfluorescence increasing in intensity
but not in size, no definite leakage; grade 2B (pathologically
significant leakage): hyperfluorescence increasing in inten-
sity and in size, definite leakage.34
Macrophage Culture from AIF-Deficient Mice
Briefly, peritoneal macrophages were collected by a previ-
ously described method.14,35,36 Peritoneal macrophages
were stimulated by injecting Thioglycollate medium into the
mouse peritoneal space and collected by washing perito-
neal space with 5 mL PBS. Cell density was adjusted to
3.5  104 cells each well of an 8-well chamber (Nunc,
Thermo Fisher Scientific, Rochester, NY) with Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal bo-
vine serum. We counted the number of TUNEL apoptotic
macrophages in the culture before and after starvation. For
starvation, cells were cultured in Dulbecco’s modified Ea-
gle’s medium without fetal bovine serum supplement and
incubated for 24 hours. The number of TUNEL apoptotic
macrophages was counted in 10 random fields per well in a
masked fashion using ImageJ software version 1.38x (NIH,
Bethesda, MD) in Harlequin (Hq) and WT mice. Values are
given as the mean  SEM of 10 replicate wells.
Statistical Analysis
The data from the TUNEL and in vitro survival assays were
analyzed with the Scheffé post hoc test using StatView
4.11J software for Macintosh (Abacus Concepts Inc.,
Berkeley, CA). Significance level was set at P  0.05 and
P  0.01. The data represent mean  SD, except for
primary culture results.
Results
Nuclear AIF Translocation in TUNEL Apoptotic
Cells in the Mouse Choroidal Neovascularization
Laser injury-induced neovascular tissue formation from
the choroid beneath the retina in 2 weeks in the WT
mouse (Figure 1A). TUNEL apoptotic cells were ob-
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vascularization. Nuclear translocation (accumulation) of
AIF was abundantly observed in TUNEL apoptotic cells
in the subretinal space and the choroid (Figure 1B). In
contrast, AIF is diffusely noted in the cytosol of the nonapo-
ptotic normal cells. Confocal microscopy also confirmed
co-localization of TUNEL and AIF in high resolution images
(Figure 1, C–F). The electron microscopy showed the mor-
phological characteristics of cellular apoptosis, namely
chromatin condensation, cellular shrinkage, and apoptotic
Figure 1. A: Apoptotic cell death and mitochondrio-nuclear translocation of
AIF in choroidal neovascularization (CNV). The CNV developed from cho-
roidal tissue into the subretinal space in the WT mouse. B: Abundant
TUNEL cells are observed in the CNV (green), and these cells also showed
nuclear accumulation of AIF (red). In contrast, diffuse weak staining of AIF
is observed in the cytosol of the nonapoptotic normal cells. C–F: Confocal
microscopy also confirms co-localization of TUNEL (C) and AIF (D) in high
resolution images. Nuclei are stained blue (E); merge is also shown (F). G
and H: The electron microscopy shows the morphological characteristics of
cellular apoptosis, namely chromatin condensation, cellular shrinkage, and
apoptotic body formation in the CNV. Original magnification: 200 (A);
400 (B–F); 750 (G) and 2500 (H). ONL, outer nuclear layer.body formation (Figure 1, G and H).AIF Deficiency Promotes CNV Expansion and
Retards Regression
Hq mice exhibit an X chromosome-linked ataxia due to
the progressive degeneration of terminally differentiated
cerebellar neurons.37,38 The Hq mutation has been iden-
tified as a proviral insertion in the apoptosis-inducing
factor (Aif) gene (alias programmed cell death 8, Pdcd8),
causing approximately an 80% reduction in AIF expres-
sion.38 In contrast to Aif knockout mice, which die in
utero,11 Hq mice are born at normal Mendelian ratios and
are healthy until the age of 3 months.
Laser-induced CNV in AIF-deficient mice led to lesions
1.7-fold larger than WT 2 weeks after laser (Figure 2, A–C).
CNV also continues to grow in size in Hq mice to 4 weeks
after laser, in contrast to WTmice (Figure 2C). CNV typically
regresses rapidly in WT mice, but persists in Hq mice to 12
weeks. To test the regulatory roles of infiltrating macro-
phage in the CNV progression, we transplanted bone mar-
row cells from EGFP transgenic wt mice into WT and AIF-
deficient mice 4 weeks before the laser injury (Figure 2, D
Figure 2. Choroidal neovascularization observed by choroidal flat mount. CNV
is visualized with fluorescent injection and analyzed with analysis software.
AIF-deficient mice (B) induce larger CNV formation than normal WT mice (A).
C: Even after 12 weeks AIF-deficient mice (black box) show persistent CNV,
whereas WT mice (white box) show regression of formed CNV. D: The EGFP-
positive WT macrophages reconstructed from transplanted bone marrow mi-
grate in the CNV stained with rhodamine conjugated concanavalin A. E: The
CNV size increased in AIF-deficient mice compared to WT mice; conversely,
CNV size was decreased in AIF-deficient mice with WT bone marrow transplan-
tation. *P  0.05, **P  0.01. Hq, Harlequin.
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from transplanted bonemarrowmigrated in the CNV (Figure
2D). The CNV size increased in AIF-deficient mice com-
pared to WT mice, whereas the size was decreased in
reverse in the AIF-deficient mice with WT bone marrow
transplantation (Figure 2E). These experiments support that
AIF deficiency resulted in enlarged CNV, which continued
to grow and exhibited less regression relative to WT mice.
AIF Deficiency Decreases Apoptosis of
Infiltrating Macrophages and Neovascular
Endothelial Cells in CNV
Vertical histological sections also showed a large area of
CNV in Hq mice in contrast to WT mice (Figure 3A). A large
number of CD45-positive myeloid lineage cells migrated in
the laser injury area and accumulated in the CNV. CD11b-
positive macrophages were also present in CNV lesions
(Figure 3B). In WT mice, TUNEL apoptotic cells were
abundant among CD11b() macrophages and CD31()
endothelial cells. AIF-deficient mice, however, showed
fewer TUNEL apoptotic cells in the CNV. To test the roles
of CD11b-positive macrophages, immunohistochemistry of
CD11b and four major angiogenic or inflammatory factors,
namely VEGF, TNF-, basic fibroblast growth factor, and
IL-1, was examined in the CNV (Figure 3C). These four
factors were expressed in CD11b positive macrophages.
VEGF was strongly expressed in neovascular tissue, espe-
cially in the macrophages. These data suggest that AIF
deficiency enhanced macrophage accumulation and an-
giogenic factor expression in the CNV.
AIF Deficiency Promotes CNV Leakage on
Fluorescein Angiography
CNV leakage can be graded by fluorescein angiography,
and in the clinical settting CNV leakage seems to corre-
late with CNV activity. AIF-deficient mice showed a trend
toward a greater number of large, leaky, grade-2B le-
sions (denoting clinical significant leakage) than WT mice
2 weeks after laser (Figure 4).
AIF Deficiency Promotes Expansion of the
Corneal Neovascularization and Retards
Regression
Laser injury-induced choroidal neovascularization captures
many of the important features of human conditions (ie,
age-related macular degeneration), although this model in-
cludes various biological responses, such as thermal burn,
tissue destruction, apoptosis and necrosis of retinal pig-
ment epithelial cells, choroidal melanocytes, photorecep-
tors, or disruption of Bruch’s membrane, and so forth. To
clarify the role of AIF in VEGF-A–dependent angiogenesis,
we used a simpler corneal pocket assay to induce angio-
genesis in the corneas with AIF-deficient mice and WT
mice. VEGF-A was implanted into these mice and the time
course of VEGF-A–induced angiogenesis was followed until
day 140. On day 6 after VEGF-A stimulation, the angiogenicarea in AIF-deficient mice was similar with WT mice, but by
day 10 AIF-deficient mice showed a significantly greater
area of corneal neovascularization than WT mice (Figure 5).
Figure 3. Immunohistochemistry for inflammatory and endothelial cells in
CNV, which is observed at the laser injury site. A larger number of myeloid
lineage cells (CD45) and macrophages (CD11b) migrate into CNV in apoptosis-
inducing factor (AIF)-deficient mice compared to WT mice (A). TUNEL inflam-
matory and endothelial cells are abundant inWTmice compared to AIF-deficient
mice (A, B). C: Immunohistochemistry of CD11b and four major angiogenic or
inflammatory factors (VEGF, TNF-, bFGF, and IL-1) were examined in the
CNV. These four factors are expressed in CD11b-positive macrophages. VEGF is
strongly expressed in neovascular tissue; however, it is especially expressed in
the macrophages. AIF-deficiency enhances macrophage accumulation and an-
giogenic factor expression in the CNV. bFGF, basic fibroblast growth factor;
Hq/Y, harlequin hemizygous male mice.The peak of the corneal neovascularization shifted from day
58 Hisatomi et al
AJP July 2012, Vol. 181, No. 128 in WT mice to day 56 in AIF-deficient mice. These data
suggest that AIF may regulate VEGF-A-dependent angio-
genesis at later stages of the process rather than the earlier
step of angiogenic sprouting.
AIF Deficiency Decreases Apoptosis of
Infiltrating Macrophages and Neovascular
Endothelial Cells in VEGF-A-Induced Corneal
Neovascularization
To investigate how AIF could regulate VEGF-A-induced an-
giogenesis, we hypothesized that cellular apoptosis by AIF
could regulate the angiogenesis and checked apoptotic
cells in VEGF-A-implanted AIF-deficient and WT mice with
TUNEL staining. Immunostaining showed abundant infil-
trated inflammatory cells (CD11b) and migrated neovascu-
Figure 5. A: VEGF-induced corneal neovascularization by corneal micropoc
neovascularization in the mouse corneas was performed using image software. AIF-defi
box). The regression of the formed neovascularization is retarded in AIF-deficient micelar endothelial cells (CD31) in AIF-deficient mice compared
to WT mice (Figure 6A). Less TUNEL cells in AIF-deficient
mice could be observed than in WT mice at day 6 and at
day 14 after VEGF-A implantation (Figure 6B). More
TUNEL apoptotic cells are noted on day 6 (early) than on
day 14 (late) in WT mice. In contrast, more apoptotic cells
are observed on day 14 (late) in AIF-deficient mice. AIF
deficiency retarded cellular apoptosis in corneal neovascu-
larization. These data suggest AIF could be important for
cellular apoptosis during VEGF-A-induced angiogenesis.
Peritoneal Macrophages Are Resistant to
Apoptosis in AIF-Deficient Mice
AIF deficiency promoted choroidal and corneal neovas-
cularization, as well as accumulation of inflammatory
cells (ie, CD45, 11b positive cells) at the local sites. To
Figure 4. Fluorescein angiography of the laser-induced
CNV. Compared to WT mice (A), AIF-deficient mice (B)
developed larger CNV formation and more severe leakage.
C: Lesions were graded on an ordinal scale based on the
spatial and temporal evolution of fluorescein leakage as
follows: grade 0 (nonleaky): no leakage, faint hyperfluores-
cence, or mottled fluorescence without leakage; grade 1
(questionable leakage): hyperfluorescent lesion without pro-
gressive increase in size or intensity; grade 2A (leaky): hy-
perfluorescence increasing in intensity but not in size; no
definite leakage; grade 2B (pathologically significant leak-
age): hyperfluorescence increasing in intensity and in size;
definite leakage. Hq/Y, harlequin hemizygous male mice.
y. B: Pellets were implanted in the cornea, and the quantitative analysis ofket assa
cient mice (black box) develop larger neovascularization than WT mice (white
compared to WT mice (A, B). Hq/Y, harlequin hemizygous male mice.
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mice are resistant to apoptotic stimuli, we examined pri-
mary macrophage culture from Hq and WT mice. Perito-
neal macrophages were collected and cultured with or
without starvation. TUNEL apoptotic macrophage in-
creased after starvation, and AIF translocation from the
cytosol into the nuclei were noted in these cells under-
going apoptosis (Figure 7). AIF deficiency diminished AIF
translocation and protected macrophages from apoptotic
cell death.
Discussion
AIF deficiency substantially expanded and prolonged
formation of neovascularization, and retarded regression
of neovascularization in both laser injury CNV- and VEGF-
induced corneal neovascularization models. Further-
more, both anatomical and functional metrics of CNV (flat
mount analysis and fluorescein angiography) supported
the notion that AIF deficiency leads to more robust and
larger neovascularization. We have reported that laser
photocoagulation incites inflammation, leading to en-
Figure 6. Immunohistochemistry for inflammatory and endothelial cells in
the corneal micropocket assay. A: Immunostaining shows abundant infil-
trated inflammatory cells (CD11b) and migrated neovascular endothelial cells
(CD31) in AIF-deficient mice compared to WT mice. B: More TUNEL
apoptotic cells are observed in WT mice than in AIF-deficient mice. TUNEL
apoptotic cells had a trend to decrease on day 14 (late) in WT mice. In
contrast, apoptotic cells had a trend to increase on day 14 (late) in AIF-
deficient mice. Hq/Y, harlequin hemizygous male mice.dothelial upregulation of intercellular adhesion mole-cule-1, which binds to CD18, mediating firm leukocyte-
endothelial adhesion and transmigration.34 Laser
photocoagulation leads to production of VEGF by ret-
inal pigment epithelial cells,20,39 stimulating proliferation
of adjacent choroidal vascular endothelium and upregu-
lation of intercellular adhesion molecule-1 expression on
endothelium.40 Circulating leukocytes, which migrate in
response to VEGF, also release VEGF, amplifying the
locally produced VEGF response as they bind to the
endothelium. In addition, leukocyte-derived cytokines
can stimulate retinal pigment epithelial cells and fibro-
blasts to express VEGF,41,42 as well as the chemotaxins
IL-8, monocyte chemotactic protein-1,43 metalloprotei-
nases44 and intercellular adhesion molecule-1.45 These
observations are consistent with our findings that AIF
deficiency protected macrophages and neovascular en-
dothelial cells from apoptosis, result in accumulation and
prolongation of inflammatory macrophages and neovas-
cular endothelial cells at the site of the developing neo-
vascularization.
Macrophages have been shown to exhibit distinct
functions during injury and repair, especially in neovas-
cularization. We have reported that macrophages are
Figure 7. Peritoneal macrophage culture under starvation. Macrophages
were collected from the peritoneal space and cultured using serum-free
medium. A: WT mice show cytosolic (normal) and nuclear (apoptotic) stain-
ing for AIF, whereas AIF-deficient mice show no staining. B: TUNEL apop-
totic macrophages increase after 24 hours of starvation in WT mice. In
contrast, macrophages from AIF-deficient mice are resistant to starvation.
*P  0.05. Hq/Y, harlequin hemizygous male mice.
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neovascularization and systemic macrophage depletion
resulted in reduced pathological neovascularization in
CNV,21 and corneal neovascularization.42 In clinical set-
tings of age-related macular degeneration, it is known
that chronic inflammatory responses caused by accumu-
lation of lipids and/or immune complex induce further
infiltration of inflammatory cells, and CNV.46 In the current
study, cultured peritoneal macrophages from AIF-defi-
cient mice are resistant to apoptotic stimuli, compared to
macrophages from WT mice. In line with these in vitro
observations, immunohistochemistry showed accumula-
tion and prolongation of macrophages at the site in both
laser-induced CNV and VEGF-induced corneal neovas-
cularization in vivo in AIF-deficient mice. Thus, AIF defi-
ciency decreased effective apoptotic clearance of ex-
cessive inflammatory cells that induced robust and larger
neovascularization.
Pathological angiogenesis is controlled by the balance
of proangiogenic factors and anti-angiogenic factors.
Several proapoptotic molecules have been identified
among anti-angiogenic factors that help regulate angio-
genesis, including Fas-ligand, thrombospondin-1, and
endostatin. The concept that the balance between pro-
and anti-apoptotic factors plays a critical role in the reg-
ulation of angiogenesis has been postulated for ocular
neovascularization.47–49 The reports, however, mainly
focus on the death receptor family (ie, Fas/Fas-Ligand)
and subsequent caspase signaling.48,50–52 Cell death
in vertebrates, however, usually proceeds via the mi-
tochondrial pathway of apoptosis.1 In the current arti-
cle, we focused on the phylogenetically old, death
receptor-independent, caspase-independent proapop-
totic factor, AIF that mainly signals mitochondrial pathway
of apoptosis in mammalian cells.7 We took advantage of
AIF-deficient mice (Hq), which cause an 80% reduction of
functional proapoptotic protein, AIF.14 Blockade of mito-
chondrial pathway of apoptosis by AIF substantially ac-
cumulated and prolonged inflammatory macrophages
and neovascular endothelial cells, resulting in expanding
and prolonging destructive inflammation and leakage at
the site. Furthermore, recent data has revealed that AIF
modulate active caspase-independent necrotic path-
ways defined as necroptosis (programmed necrosis) ad-
ditionally to apoptosis.53 AIF and the key executioner,
such as the kinase, the receptor-interacting protein 1
have become potential therapeutic targets in apoptosis/
necrosis.14,54 In the current article, we hypothesized that
decreased apoptotic cell death of inflammatory/endothe-
lial cells may modulate CNV. The bone marrow transplan-
tation experiments also support the hypothesis that re-
constructed WT macrophages partially reversed CNV
modulation in AIF-deficient mice. Further study is needed
to clarify the direct molecular mechanism underlying the
phenomena.
Therapeutic strategies directed against pathological
neovascularization via appropriate apoptotic clearance
of excessive inflammatory cells or endothelial cells may
have potential as a novel clinically relevant approach in
addition to conventional therapies.Acknowledgments
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